Bioengineered Liver Tissue
Grow functional liver tissue to repair or replace what disease destroys
The goal is to grow functional liver tissue — to repair or replace liver destroyed by disease, easing the transplant shortage. For the people this touches, it is not theory; it is whether an ordinary day is shaped by illness or by health.
The liver performs hundreds of vital jobs and is the body’s great regenerator — yet chronic disease and scarring can finally overwhelm even that power, and demand for transplants far outstrips supply. Growing functional liver tissue, reversing fibrosis, and restoring the liver’s many functions would transform liver failure. The liver does the silent work that keeps us alive — and growing new liver tissue could end the wait for a scarce transplant.
We are building the capability to bioengineer liver tissue: from liver organoids, hepatocyte therapies, and engineered constructs that perform the liver’s work. The path moves from today’s established care toward tomorrow’s regenerative tools, with each stage labeled for exactly how real it is.
How it works
Liver organoids Demonstrated in research
Lab-grown liver organoids reproduce key liver functions and are advancing in research.
Hepatocyte cell therapy Demonstrated in research
Transplanting liver cells can support failing livers in research and early studies.
Engineered liver constructs Frontier
Building large, vascularized, durable liver tissue for implant is a frontier.
Pairing repair with rehabilitation Clinical
Combining tissue or cell repair with intensive, targeted rehabilitation drives the fullest functional recovery — established in practice.
Cited as evidence the capability is real — not as partners or endorsers.
Government & programs
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) · NIH liver-disease programs. These public programs fund the foundational research that shows the capability is real.
Universities & institutes
Academic hepatology and liver-bioengineering research centers. Academic laboratories carry that science from discovery toward the clinic.
Enabling science base
hepatocyte biology · liver organoids · anti-fibrotic therapy · liver tissue engineering. — the established disciplines this capability is built upon.
The technologies: bioengineered liver tissue and organoids, hepatocyte cell therapies, anti-fibrotic drugs that reverse scarring, and the support and protection medicine offers today.
Organoids Demonstrated
Liver organoids reproduce key functions.
Cell therapy Demonstrated
Liver-cell transplants support failing livers.
Engineered tissue Frontier
Large implantable liver tissue is early-stage.
Clinical translation underway Clinical trials
Several restorative approaches have moved from the lab into human trials — the bridge from demonstrated biology to everyday care.
The honest challenges: organoids and cell therapy are advancing, but building large, blood-supplied, durable liver tissue for transplant remains frontier — it depends on vascularization maturing too. Getting new cells and tissue to survive, connect, and function durably in a living person — not just in a dish or an animal — is the central work, and it is exactly where the most careful, best-funded research is now aimed. We show where each piece stands, so the promise is never mistaken for the proof.
The future, fully built
A failing liver is repaired or replaced with engineered tissue — grown from cells, performing the liver’s work — so liver failure no longer waits on a scarce transplant. — with every step on this page marked for exactly how far the real science has come.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Liver organoids
Reproduce key functions in research. Stage: Demonstrated.
Hepatocyte therapy
Supports failing livers in early studies. Stage: Demonstrated.
Engineered liver
Large implantable tissue is early-stage. Stage: Frontier.
Honest framing
Real organizations are cited as evidence the capability is real — not as partners or endorsers. Organoids and cell therapy are demonstrated; transplantable engineered liver in people is frontier.
Where it stands
Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.
Help build this future
Every signature grows the movement to make bioengineered liver tissue real — and free at the point of need.